Cargando…
Carrier-Mediated Drug Uptake in Fungal Pathogens
Candida, Aspergillus, and Cryptococcus species are the most frequent cause of severe human fungal infections. Clinically relevant antifungal drugs are scarce, and their effectiveness are hampered by the ability of fungal cells to develop drug resistance mechanisms. Drug effectiveness and drug resist...
Autores principales: | Galocha, Mónica, Costa, Inês Vieira, Teixeira, Miguel Cacho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697741/ https://www.ncbi.nlm.nih.gov/pubmed/33182427 http://dx.doi.org/10.3390/genes11111324 |
Ejemplares similares
-
Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection
por: Pais, Pedro, et al.
Publicado: (2019) -
Genome-Scale Metabolic Model of the Human Pathogen Candida albicans: A Promising Platform for Drug Target Prediction
por: Viana, Romeu, et al.
Publicado: (2020) -
Host-Pathogen Interactions Mediated by MDR Transporters in Fungi: As Pleiotropic as it Gets!
por: Cavalheiro, Mafalda, et al.
Publicado: (2018) -
Draft Genome Sequences of Three Clinical Isolates of the Pathogenic Yeast Candida glabrata
por: Pais, Pedro, et al.
Publicado: (2019) -
Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants
por: Pais, Pedro, et al.
Publicado: (2022)